Clinical Trial Update: Vagal Approaches on Long COVID-19 [NA]

View source ↗

Summary

Leidos Life Sciences completed a clinical trial evaluating vagal approaches for long COVID symptoms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Long Covid
• Post-acute Sequelae of Sars-cov-2 Infection

Snippet

Sponsor: Leidos Life Sciences | Conditions: Long COVID Symptoms | NA | Status: COMPLETED